| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 20 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-02-20 |
4 |
B |
$24.95 |
$499,000 |
I/I |
20,000 |
13,145,028 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-06-05 |
4 |
B |
$9.08 |
$499,173 |
I/I |
54,975 |
54,975 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-08-14 |
4 |
B |
$21.35 |
$499,590 |
I/I |
23,400 |
12,506,705 |
2.25 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2023-07-24 |
4 |
B |
$2.75 |
$499,950 |
I/I |
181,800 |
1,883,656 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-03-05 |
4 |
S |
$2.67 |
$501,920 |
I/I |
(187,985) |
4,084,792 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-28 |
4 |
B |
$12.14 |
$518,140 |
I/I |
42,666 |
225,833 |
2.1 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-19 |
4 |
B |
$16.67 |
$531,940 |
I/I |
31,910 |
10,714,001 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-02-02 |
4 |
A |
$9.87 |
$534,283 |
I/I |
54,132 |
1,262,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-20 |
4 |
B |
$9.40 |
$557,956 |
I/I |
59,357 |
14,361,285 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-27 |
4 |
B |
$12.35 |
$564,262 |
I/I |
45,700 |
204,501 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2018-01-22 |
4 |
S |
$48.50 |
$582,031 |
I/I |
(12,000) |
3,414,053 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-06 |
4 |
B |
$3.90 |
$610,100 |
D/D |
154,000 |
3,354,890 |
2.45 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-05-23 |
4 |
A |
$18.87 |
$615,162 |
I/I |
32,600 |
2,086,323 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-09-29 |
4 |
B |
$15.18 |
$616,308 |
I/I |
40,600 |
10,823,773 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2013-12-20 |
4 |
S |
$96.40 |
$621,973 |
I/I |
(6,452) |
147,967 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2018-03-01 |
4 |
B |
$62.59 |
$625,910 |
D/D |
10,000 |
626,142 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-09 |
4 |
B |
$3.60 |
$626,615 |
D/D |
151,782 |
3,506,672 |
2.45 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-11 |
4 |
B |
$10.77 |
$627,047 |
I/I |
58,220 |
646,126 |
2.1 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.70 |
$650,038 |
D/D |
(47,287) |
2,892,275 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.67 |
$651,690 |
D/D |
(47,382) |
2,844,893 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2017-12-12 |
4 |
OE |
$15.74 |
$653,024 |
D/D |
31,164 |
3,385,375 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2017-12-12 |
4 |
D |
$40.01 |
$653,043 |
D/D |
(16,322) |
3,369,053 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-02-03 |
4 |
B |
$13.09 |
$655,809 |
I/I |
50,100 |
11,318,278 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-13 |
4 |
A |
$13.23 |
$661,500 |
I/I |
50,000 |
1,799,423 |
0 |
- |
|
634 Records found
|
|
Page 20 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
